Oncogenic co-operation in β-cell tumorigenesis

Endocrine-Related Cancer

Volumn 8, Issue 4, 2001, Pages 307-314

  Pelengaris, S ^a   Khan, M ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; RETINOBLASTOMA PROTEIN; SOMATOMEDIN B; VIRUS LARGE T ANTIGEN;

ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; DIABETES MELLITUS; HUMAN; INSULINOMA; MALIGNANT TRANSFORMATION; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; ONCOGENE C MYC; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL TUMOR; PROTO ONCOGENE; REVIEW; TRANSGENIC MOUSE;

ADENOMA, ISLET CELL; ADULT; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CHILD; DISEASE PROGRESSION; GENES, MYC; GENES, RAS; HUMANS; INSULINOMA; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; ONCOGENES; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENES; SIMIAN VIRUS 40;

EID: 0035666843     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0080307     Document Type: Review

References (38)

1. Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death
2. Pancreatic islet cell carcinoma: Clinical features of 52 patients
3. Positional cloning of the gene for multiple endocrine neoplasia type 1
4. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
5. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
6. Lack of MEN1 gene mutations in 27 sporadic insulinomas
7. Control of cell proliferation by Myc family genes
8. A matter of life and cell death
9. Induction of apoptosis in fibroblasts by c-myc protein
10. Reversible tumorigenesis by Myc in haematopoeitic lineages
11. Transient excess of Myc activity can elicit genomic instability and tumorigenesis
12. Pancreatic nesidioblastosis in adults
13. Mitochondria and apoptosis
14. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
15. The hallmarks of cancer
16. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines
17. c-Myc-induced sensitisation to apoptosis is mediated through cytochrome c release
18. An in vitro model of the early genetic events in multistage carcinogenesis of malignant insulinoma
19. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
20. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
21. Myc function and regulation
22. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer
23. The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors
24. Nesidioblastosis associated with insulin-mediated hypoglycemia in an adult
25. Myc oncogenes and human neoplastic disease
26. Multiple genetic alterations in malignant metastatic insulinomas
27. Molecular genetics of malignant insulinoma
28. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
29. Action of Myc in vivo - Proliferation and apoptosis
30. Mechanisms of apoptosis by c-Myc
31. Functioning insulinoma - Incidence, recurrence, and long-term survival of patients: A 60-year study
32. Control of c-myc regulation in normal and neoplastic cells
33. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
34. Progenitor tumours from Eμ-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival
35. Apoptosis in neuroendocrine tumors
36. Oncogene expression in gastroenteropancreatic neuroendocrine tumours. Implications for pathogenesis
37. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors
38. Multiple endocrine neoplasia type 1